LSE:BSFA
BSF Enterprise PLC
Investment Banking and Brokerage Services
0.875p 0p 0.00% (as of close on 15/7/26)
| Market cap (m) | £1.7 |
| Enterprise value (m) | £1.5 |
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.
Last Updated: 06/07/2026
BSF Enterprise reported a pretax loss of GBP1.0 million for the six months ended March 31. Revenue was GBP18,785; administrative costs were GBP1.0 million; no grant income was recognised. Cash at March 31 was GBP60,174. No dividends were declared.
The cost base reflected higher legal and professional fees linked to a proposed fundraising, expenses from the corneal development collaboration with the Université de Montréal, and greater consumables to accelerate lab-grown leather development. The company said intellectual property is central to its strategy and that it remains in an investment and development phase.
